Pharma & Healthcare
Global Eosinophilic Esophagitis Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 189389
- Pages: 91
- Figures: 91
- Views: 30
The global Eosinophilic Esophagitis Drug market size was US$ 144 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
The global Eosinophilic Esophagitis Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
By Type: (Dominant Segment vs High-Margin Innovation)
Budesonide
Fluticasone
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Clinics
Drugstore
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AstraZeneca in Europe)
- Emerging Product Trends: Budesonide adoption vs. Fluticasone premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Eosinophilic Esophagitis Drug market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Fluticasone in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Budesonide dominance in Europe vs. Fluticasone demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
The global Eosinophilic Esophagitis Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron
By Type: (Dominant Segment vs High-Margin Innovation)
Budesonide
Fluticasone
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals
Clinics
Drugstore
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AstraZeneca in Europe)
- Emerging Product Trends: Budesonide adoption vs. Fluticasone premiumization
- Demand-Side Dynamics: Hospitals growth in China vs. Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Eosinophilic Esophagitis Drug market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Fluticasone in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Budesonide dominance in Europe vs. Fluticasone demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Eosinophilic Esophagitis Drug Product Scope
1.2 Eosinophilic Esophagitis Drug by Type
1.2.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020 & 2024 & 2031)
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Eosinophilic Esophagitis Drug by Application
1.3.1 Global Eosinophilic Esophagitis Drug Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts (2020-2031)
1.4.1 Global Eosinophilic Esophagitis Drug Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Eosinophilic Esophagitis Drug Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Eosinophilic Esophagitis Drug Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Eosinophilic Esophagitis Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Eosinophilic Esophagitis Drug Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2025)
2.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2025)
2.3 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.2 Europe Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.3 Asia-Pacific Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.4 South America Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.5 Middle East and Africa Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Type (2020-2025)
3.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
3.1.2 Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2025)
3.1.3 Global Eosinophilic Esophagitis Drug Price by Type (2020-2025)
3.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2026-2031)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2026-2031)
3.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Type (2026-2031)
3.3 Different Types Eosinophilic Esophagitis Drug Representative Players
4 Global Market Size by Application
4.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Application (2020-2025)
4.1.1 Global Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
4.1.2 Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2025)
4.1.3 Global Eosinophilic Esophagitis Drug Price by Application (2020-2025)
4.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2026-2031)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2026-2031)
4.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Eosinophilic Esophagitis Drug Application
5 Competition Landscape by Players
5.1 Global Eosinophilic Esophagitis Drug Sales by Players (2020-2025)
5.2 Global Top Eosinophilic Esophagitis Drug Players by Revenue (2020-2025)
5.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
5.4 Global Eosinophilic Esophagitis Drug Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Eosinophilic Esophagitis Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Eosinophilic Esophagitis Drug, Product Type & Application
5.7 Global Key Manufacturers of Eosinophilic Esophagitis Drug, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Eosinophilic Esophagitis Drug Sales by Company
6.1.1.1 North America Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.1.1.2 North America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.1.2 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.1.3 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.1.4 North America Eosinophilic Esophagitis Drug Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Eosinophilic Esophagitis Drug Sales by Company
6.2.1.1 Europe Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.2.1.2 Europe Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.2.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.2.3 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.2.4 Europe Eosinophilic Esophagitis Drug Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Company
6.3.1.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.3.1.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.3.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.3.4 Asia-Pacific Eosinophilic Esophagitis Drug Major Customer
6.3.5 Asia-Pacific Market Trend and Opportunities
6.4 South America Market: Players, Segments, Downstream and Major Customers
6.4.1 South America Eosinophilic Esophagitis Drug Sales by Company
6.4.1.1 South America Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.4.1.2 South America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.4.2 South America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.4.3 South America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.4.4 South America Eosinophilic Esophagitis Drug Major Customer
6.4.5 South America Market Trend and Opportunities
6.5 Middle East and Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Company
6.5.1.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.5.1.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.5.2 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.5.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.5.4 Middle East and Africa Eosinophilic Esophagitis Drug Major Customer
6.5.5 Middle East and Africa Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AstraZeneca
7.1.1 AstraZeneca Company Information
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
7.1.5 AstraZeneca Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Business Overview
7.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GSK Eosinophilic Esophagitis Drug Products Offered
7.2.5 GSK Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Business Overview
7.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bayer Eosinophilic Esophagitis Drug Products Offered
7.3.5 Bayer Recent Development
7.4 Adare Pharmaceuticals
7.4.1 Adare Pharmaceuticals Company Information
7.4.2 Adare Pharmaceuticals Business Overview
7.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
7.4.5 Adare Pharmaceuticals Recent Development
7.5 DBV Technologies
7.5.1 DBV Technologies Company Information
7.5.2 DBV Technologies Business Overview
7.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.5.4 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
7.5.5 DBV Technologies Recent Development
7.6 Dr. Falk Pharma
7.6.1 Dr. Falk Pharma Company Information
7.6.2 Dr. Falk Pharma Business Overview
7.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
7.6.5 Dr. Falk Pharma Recent Development
7.7 Quorum Innovations
7.7.1 Quorum Innovations Company Information
7.7.2 Quorum Innovations Business Overview
7.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
7.7.5 Quorum Innovations Recent Development
7.8 Takeda
7.8.1 Takeda Company Information
7.8.2 Takeda Business Overview
7.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Takeda Eosinophilic Esophagitis Drug Products Offered
7.8.5 Takeda Recent Development
7.9 Calypso
7.9.1 Calypso Company Information
7.9.2 Calypso Business Overview
7.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Calypso Eosinophilic Esophagitis Drug Products Offered
7.9.5 Calypso Recent Development
7.10 Celgene
7.10.1 Celgene Company Information
7.10.2 Celgene Business Overview
7.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Celgene Eosinophilic Esophagitis Drug Products Offered
7.10.5 Celgene Recent Development
7.11 Regeneron
7.11.1 Regeneron Company Information
7.11.2 Regeneron Business Overview
7.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Regeneron Eosinophilic Esophagitis Drug Products Offered
7.11.5 Regeneron Recent Development
8 Eosinophilic Esophagitis Drug Manufacturing Cost Analysis
8.1 Eosinophilic Esophagitis Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
8.4 Eosinophilic Esophagitis Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Eosinophilic Esophagitis Drug Distributors List
9.3 Eosinophilic Esophagitis Drug Customers
10 Eosinophilic Esophagitis Drug Market Dynamics
10.1 Eosinophilic Esophagitis Drug Industry Trends
10.2 Eosinophilic Esophagitis Drug Market Drivers
10.3 Eosinophilic Esophagitis Drug Market Challenges
10.4 Eosinophilic Esophagitis Drug Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Eosinophilic Esophagitis Drug Product Scope
1.2 Eosinophilic Esophagitis Drug by Type
1.2.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020 & 2024 & 2031)
1.2.2 Budesonide
1.2.3 Fluticasone
1.2.4 Others
1.3 Eosinophilic Esophagitis Drug by Application
1.3.1 Global Eosinophilic Esophagitis Drug Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstore
1.4 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts (2020-2031)
1.4.1 Global Eosinophilic Esophagitis Drug Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Eosinophilic Esophagitis Drug Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Eosinophilic Esophagitis Drug Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Eosinophilic Esophagitis Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Eosinophilic Esophagitis Drug Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2025)
2.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2025)
2.3 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Eosinophilic Esophagitis Drug Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.2 Europe Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.3 Asia-Pacific Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.4 South America Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
2.4.5 Middle East and Africa Eosinophilic Esophagitis Drug Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Type (2020-2025)
3.1.1 Global Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
3.1.2 Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2025)
3.1.3 Global Eosinophilic Esophagitis Drug Price by Type (2020-2025)
3.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2026-2031)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2026-2031)
3.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Type (2026-2031)
3.3 Different Types Eosinophilic Esophagitis Drug Representative Players
4 Global Market Size by Application
4.1 Global Eosinophilic Esophagitis Drug Historic Market Review by Application (2020-2025)
4.1.1 Global Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
4.1.2 Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2025)
4.1.3 Global Eosinophilic Esophagitis Drug Price by Application (2020-2025)
4.2 Global Eosinophilic Esophagitis Drug Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2026-2031)
4.2.2 Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2026-2031)
4.2.3 Global Eosinophilic Esophagitis Drug Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Eosinophilic Esophagitis Drug Application
5 Competition Landscape by Players
5.1 Global Eosinophilic Esophagitis Drug Sales by Players (2020-2025)
5.2 Global Top Eosinophilic Esophagitis Drug Players by Revenue (2020-2025)
5.3 Global Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
5.4 Global Eosinophilic Esophagitis Drug Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Eosinophilic Esophagitis Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Eosinophilic Esophagitis Drug, Product Type & Application
5.7 Global Key Manufacturers of Eosinophilic Esophagitis Drug, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Eosinophilic Esophagitis Drug Sales by Company
6.1.1.1 North America Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.1.1.2 North America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.1.2 North America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.1.3 North America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.1.4 North America Eosinophilic Esophagitis Drug Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Eosinophilic Esophagitis Drug Sales by Company
6.2.1.1 Europe Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.2.1.2 Europe Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.2.2 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.2.3 Europe Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.2.4 Europe Eosinophilic Esophagitis Drug Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Company
6.3.1.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.3.1.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.3.3 Asia-Pacific Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.3.4 Asia-Pacific Eosinophilic Esophagitis Drug Major Customer
6.3.5 Asia-Pacific Market Trend and Opportunities
6.4 South America Market: Players, Segments, Downstream and Major Customers
6.4.1 South America Eosinophilic Esophagitis Drug Sales by Company
6.4.1.1 South America Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.4.1.2 South America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.4.2 South America Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.4.3 South America Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.4.4 South America Eosinophilic Esophagitis Drug Major Customer
6.4.5 South America Market Trend and Opportunities
6.5 Middle East and Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Company
6.5.1.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales by Company (2020-2025)
6.5.1.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
6.5.2 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Type (2020-2025)
6.5.3 Middle East and Africa Eosinophilic Esophagitis Drug Sales Breakdown by Application (2020-2025)
6.5.4 Middle East and Africa Eosinophilic Esophagitis Drug Major Customer
6.5.5 Middle East and Africa Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AstraZeneca
7.1.1 AstraZeneca Company Information
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AstraZeneca Eosinophilic Esophagitis Drug Products Offered
7.1.5 AstraZeneca Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Business Overview
7.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GSK Eosinophilic Esophagitis Drug Products Offered
7.2.5 GSK Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Business Overview
7.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bayer Eosinophilic Esophagitis Drug Products Offered
7.3.5 Bayer Recent Development
7.4 Adare Pharmaceuticals
7.4.1 Adare Pharmaceuticals Company Information
7.4.2 Adare Pharmaceuticals Business Overview
7.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Products Offered
7.4.5 Adare Pharmaceuticals Recent Development
7.5 DBV Technologies
7.5.1 DBV Technologies Company Information
7.5.2 DBV Technologies Business Overview
7.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.5.4 DBV Technologies Eosinophilic Esophagitis Drug Products Offered
7.5.5 DBV Technologies Recent Development
7.6 Dr. Falk Pharma
7.6.1 Dr. Falk Pharma Company Information
7.6.2 Dr. Falk Pharma Business Overview
7.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Dr. Falk Pharma Eosinophilic Esophagitis Drug Products Offered
7.6.5 Dr. Falk Pharma Recent Development
7.7 Quorum Innovations
7.7.1 Quorum Innovations Company Information
7.7.2 Quorum Innovations Business Overview
7.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Quorum Innovations Eosinophilic Esophagitis Drug Products Offered
7.7.5 Quorum Innovations Recent Development
7.8 Takeda
7.8.1 Takeda Company Information
7.8.2 Takeda Business Overview
7.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Takeda Eosinophilic Esophagitis Drug Products Offered
7.8.5 Takeda Recent Development
7.9 Calypso
7.9.1 Calypso Company Information
7.9.2 Calypso Business Overview
7.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Calypso Eosinophilic Esophagitis Drug Products Offered
7.9.5 Calypso Recent Development
7.10 Celgene
7.10.1 Celgene Company Information
7.10.2 Celgene Business Overview
7.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Celgene Eosinophilic Esophagitis Drug Products Offered
7.10.5 Celgene Recent Development
7.11 Regeneron
7.11.1 Regeneron Company Information
7.11.2 Regeneron Business Overview
7.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Regeneron Eosinophilic Esophagitis Drug Products Offered
7.11.5 Regeneron Recent Development
8 Eosinophilic Esophagitis Drug Manufacturing Cost Analysis
8.1 Eosinophilic Esophagitis Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
8.4 Eosinophilic Esophagitis Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Eosinophilic Esophagitis Drug Distributors List
9.3 Eosinophilic Esophagitis Drug Customers
10 Eosinophilic Esophagitis Drug Market Dynamics
10.1 Eosinophilic Esophagitis Drug Industry Trends
10.2 Eosinophilic Esophagitis Drug Market Drivers
10.3 Eosinophilic Esophagitis Drug Market Challenges
10.4 Eosinophilic Esophagitis Drug Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Eosinophilic Esophagitis Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Eosinophilic Esophagitis Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Eosinophilic Esophagitis Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Eosinophilic Esophagitis Drug Sales (K Units) by Region (2020-2025)
Table 5. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2025)
Table 6. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Eosinophilic Esophagitis Drug Revenue Share by Region (2020-2025)
Table 8. Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Eosinophilic Esophagitis Drug Revenue Share Forecast by Region (2026-2031)
Table 12. Global Eosinophilic Esophagitis Drug Sales by Type (K Units) & (2020-2025)
Table 13. Global Eosinophilic Esophagitis Drug Sales Share by Type (2020-2025)
Table 14. Global Eosinophilic Esophagitis Drug Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Eosinophilic Esophagitis Drug Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Eosinophilic Esophagitis Drug Sales by Type (K Units) & (2026-2031)
Table 17. Global Eosinophilic Esophagitis Drug Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Eosinophilic Esophagitis Drug Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Eosinophilic Esophagitis Drug Sales by Application (K Units) & (2020-2025)
Table 21. Global Eosinophilic Esophagitis Drug Sales Share by Application (2020-2025)
Table 22. Global Eosinophilic Esophagitis Drug Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Eosinophilic Esophagitis Drug Price by Application (USD/Unit) & (2020-2025)
Table 24. Global Eosinophilic Esophagitis Drug Sales by Application (K Units) & (2026-2031)
Table 25. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Eosinophilic Esophagitis Drug Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Eosinophilic Esophagitis Drug Application
Table 28. Global Eosinophilic Esophagitis Drug Sales by Company (K Units) & (2020-2025)
Table 29. Global Eosinophilic Esophagitis Drug Sales Share by Company (2020-2025)
Table 30. Global Eosinophilic Esophagitis Drug Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2020-2025)
Table 32. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
Table 33. Global Market Eosinophilic Esophagitis Drug Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Eosinophilic Esophagitis Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Eosinophilic Esophagitis Drug, Product Type & Application
Table 36. Global Key Manufacturers of Eosinophilic Esophagitis Drug, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 39. North America Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 40. North America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 42. North America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 43. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 44. North America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 45. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 46. Europe Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 47. Europe Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 48. Europe Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 50. Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 51. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 52. Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 53. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 54. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 55. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 56. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 57. Asia-Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 58. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 59. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 60. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 61. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 62. South America Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 63. South America Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 64. South America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 65. South America Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 66. South America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 67. South America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 68. South America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 69. South America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 70. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 71. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 72. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 73. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 74. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 75. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 76. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 77. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 78. AstraZeneca Company Information
Table 79. AstraZeneca Description and Business Overview
Table 80. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 82. AstraZeneca Recent Development
Table 83. GSK Company Information
Table 84. GSK Description and Business Overview
Table 85. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. GSK Eosinophilic Esophagitis Drug Product
Table 87. GSK Recent Development
Table 88. Bayer Company Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Bayer Eosinophilic Esophagitis Drug Product
Table 92. Bayer Recent Development
Table 93. Adare Pharmaceuticals Company Information
Table 94. Adare Pharmaceuticals Description and Business Overview
Table 95. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 97. Adare Pharmaceuticals Recent Development
Table 98. DBV Technologies Company Information
Table 99. DBV Technologies Description and Business Overview
Table 100. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 102. DBV Technologies Recent Development
Table 103. Dr. Falk Pharma Company Information
Table 104. Dr. Falk Pharma Description and Business Overview
Table 105. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 107. Dr. Falk Pharma Recent Development
Table 108. Quorum Innovations Company Information
Table 109. Quorum Innovations Description and Business Overview
Table 110. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 112. Quorum Innovations Recent Development
Table 113. Takeda Company Information
Table 114. Takeda Description and Business Overview
Table 115. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Takeda Eosinophilic Esophagitis Drug Product
Table 117. Takeda Recent Development
Table 118. Calypso Company Information
Table 119. Calypso Description and Business Overview
Table 120. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Calypso Eosinophilic Esophagitis Drug Product
Table 122. Calypso Recent Development
Table 123. Celgene Company Information
Table 124. Celgene Description and Business Overview
Table 125. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Celgene Eosinophilic Esophagitis Drug Product
Table 127. Celgene Recent Development
Table 128. Regeneron Company Information
Table 129. Regeneron Description and Business Overview
Table 130. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Regeneron Eosinophilic Esophagitis Drug Product
Table 132. Regeneron Recent Development
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Eosinophilic Esophagitis Drug Distributors List
Table 136. Eosinophilic Esophagitis Drug Customers List
Table 137. Eosinophilic Esophagitis Drug Market Trends
Table 138. Eosinophilic Esophagitis Drug Market Drivers
Table 139. Eosinophilic Esophagitis Drug Market Challenges
Table 140. Eosinophilic Esophagitis Drug Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Product Picture
Figure 6. Others Product Picture
Figure 7. Global Eosinophilic Esophagitis Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals Examples
Figure 10. Clinics Examples
Figure 11. Drugstore Examples
Figure 12. Global Eosinophilic Esophagitis Drug Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Eosinophilic Esophagitis Drug Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Eosinophilic Esophagitis Drug Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 16. Eosinophilic Esophagitis Drug Report Years Considered
Figure 17. Global Market Eosinophilic Esophagitis Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 23. Asia-Pacific Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Asia-Pacific Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 25. South America Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. South America Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 27. Middle East and Africa Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Middle East and Africa Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2020-2025)
Figure 30. Global Eosinophilic Esophagitis Drug Sales Share by Type (2026-2031)
Figure 31. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2026-2031)
Figure 32. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2020-2025)
Figure 33. Global Eosinophilic Esophagitis Drug Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Eosinophilic Esophagitis Drug Sales Share by Application (2026-2031)
Figure 35. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2026-2031)
Figure 36. Global Eosinophilic Esophagitis Drug Sales Share by Company (2024)
Figure 37. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2024)
Figure 38. Global 5 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue in Eosinophilic Esophagitis Drug: 2020 & 2024
Figure 39. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Eosinophilic Esophagitis Drug
Figure 41. Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure 42. Eosinophilic Esophagitis Drug Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Table 1. Global Eosinophilic Esophagitis Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Eosinophilic Esophagitis Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Eosinophilic Esophagitis Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Eosinophilic Esophagitis Drug Sales (K Units) by Region (2020-2025)
Table 5. Global Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2025)
Table 6. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Eosinophilic Esophagitis Drug Revenue Share by Region (2020-2025)
Table 8. Global Eosinophilic Esophagitis Drug Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Eosinophilic Esophagitis Drug Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Eosinophilic Esophagitis Drug Revenue Share Forecast by Region (2026-2031)
Table 12. Global Eosinophilic Esophagitis Drug Sales by Type (K Units) & (2020-2025)
Table 13. Global Eosinophilic Esophagitis Drug Sales Share by Type (2020-2025)
Table 14. Global Eosinophilic Esophagitis Drug Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Eosinophilic Esophagitis Drug Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Eosinophilic Esophagitis Drug Sales by Type (K Units) & (2026-2031)
Table 17. Global Eosinophilic Esophagitis Drug Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Eosinophilic Esophagitis Drug Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Eosinophilic Esophagitis Drug Sales by Application (K Units) & (2020-2025)
Table 21. Global Eosinophilic Esophagitis Drug Sales Share by Application (2020-2025)
Table 22. Global Eosinophilic Esophagitis Drug Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Eosinophilic Esophagitis Drug Price by Application (USD/Unit) & (2020-2025)
Table 24. Global Eosinophilic Esophagitis Drug Sales by Application (K Units) & (2026-2031)
Table 25. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Eosinophilic Esophagitis Drug Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Eosinophilic Esophagitis Drug Application
Table 28. Global Eosinophilic Esophagitis Drug Sales by Company (K Units) & (2020-2025)
Table 29. Global Eosinophilic Esophagitis Drug Sales Share by Company (2020-2025)
Table 30. Global Eosinophilic Esophagitis Drug Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2020-2025)
Table 32. Global Eosinophilic Esophagitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
Table 33. Global Market Eosinophilic Esophagitis Drug Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Eosinophilic Esophagitis Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Eosinophilic Esophagitis Drug, Product Type & Application
Table 36. Global Key Manufacturers of Eosinophilic Esophagitis Drug, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 39. North America Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 40. North America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 42. North America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 43. North America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 44. North America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 45. North America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 46. Europe Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 47. Europe Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 48. Europe Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 50. Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 51. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 52. Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 53. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 54. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 55. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 56. Asia-Pacific Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 57. Asia-Pacific Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 58. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 59. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 60. Asia-Pacific Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 61. Asia-Pacific Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 62. South America Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 63. South America Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 64. South America Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 65. South America Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 66. South America Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 67. South America Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 68. South America Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 69. South America Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 70. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 71. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 72. Middle East and Africa Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 73. Middle East and Africa Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 74. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 75. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 76. Middle East and Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 77. Middle East and Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Table 78. AstraZeneca Company Information
Table 79. AstraZeneca Description and Business Overview
Table 80. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. AstraZeneca Eosinophilic Esophagitis Drug Product
Table 82. AstraZeneca Recent Development
Table 83. GSK Company Information
Table 84. GSK Description and Business Overview
Table 85. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. GSK Eosinophilic Esophagitis Drug Product
Table 87. GSK Recent Development
Table 88. Bayer Company Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Bayer Eosinophilic Esophagitis Drug Product
Table 92. Bayer Recent Development
Table 93. Adare Pharmaceuticals Company Information
Table 94. Adare Pharmaceuticals Description and Business Overview
Table 95. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product
Table 97. Adare Pharmaceuticals Recent Development
Table 98. DBV Technologies Company Information
Table 99. DBV Technologies Description and Business Overview
Table 100. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. DBV Technologies Eosinophilic Esophagitis Drug Product
Table 102. DBV Technologies Recent Development
Table 103. Dr. Falk Pharma Company Information
Table 104. Dr. Falk Pharma Description and Business Overview
Table 105. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product
Table 107. Dr. Falk Pharma Recent Development
Table 108. Quorum Innovations Company Information
Table 109. Quorum Innovations Description and Business Overview
Table 110. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Quorum Innovations Eosinophilic Esophagitis Drug Product
Table 112. Quorum Innovations Recent Development
Table 113. Takeda Company Information
Table 114. Takeda Description and Business Overview
Table 115. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Takeda Eosinophilic Esophagitis Drug Product
Table 117. Takeda Recent Development
Table 118. Calypso Company Information
Table 119. Calypso Description and Business Overview
Table 120. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Calypso Eosinophilic Esophagitis Drug Product
Table 122. Calypso Recent Development
Table 123. Celgene Company Information
Table 124. Celgene Description and Business Overview
Table 125. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Celgene Eosinophilic Esophagitis Drug Product
Table 127. Celgene Recent Development
Table 128. Regeneron Company Information
Table 129. Regeneron Description and Business Overview
Table 130. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Regeneron Eosinophilic Esophagitis Drug Product
Table 132. Regeneron Recent Development
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Eosinophilic Esophagitis Drug Distributors List
Table 136. Eosinophilic Esophagitis Drug Customers List
Table 137. Eosinophilic Esophagitis Drug Market Trends
Table 138. Eosinophilic Esophagitis Drug Market Drivers
Table 139. Eosinophilic Esophagitis Drug Market Challenges
Table 140. Eosinophilic Esophagitis Drug Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Product Picture
Figure 6. Others Product Picture
Figure 7. Global Eosinophilic Esophagitis Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Eosinophilic Esophagitis Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals Examples
Figure 10. Clinics Examples
Figure 11. Drugstore Examples
Figure 12. Global Eosinophilic Esophagitis Drug Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Eosinophilic Esophagitis Drug Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Eosinophilic Esophagitis Drug Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 16. Eosinophilic Esophagitis Drug Report Years Considered
Figure 17. Global Market Eosinophilic Esophagitis Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Eosinophilic Esophagitis Drug Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 23. Asia-Pacific Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Asia-Pacific Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 25. South America Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. South America Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 27. Middle East and Africa Eosinophilic Esophagitis Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Middle East and Africa Eosinophilic Esophagitis Drug Sales (K Units) Growth Rate (2020-2031)
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2020-2025)
Figure 30. Global Eosinophilic Esophagitis Drug Sales Share by Type (2026-2031)
Figure 31. Global Eosinophilic Esophagitis Drug Revenue Share by Type (2026-2031)
Figure 32. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2020-2025)
Figure 33. Global Eosinophilic Esophagitis Drug Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Eosinophilic Esophagitis Drug Sales Share by Application (2026-2031)
Figure 35. Global Eosinophilic Esophagitis Drug Revenue Share by Application (2026-2031)
Figure 36. Global Eosinophilic Esophagitis Drug Sales Share by Company (2024)
Figure 37. Global Eosinophilic Esophagitis Drug Revenue Share by Company (2024)
Figure 38. Global 5 Largest Eosinophilic Esophagitis Drug Players Market Share by Revenue in Eosinophilic Esophagitis Drug: 2020 & 2024
Figure 39. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Eosinophilic Esophagitis Drug
Figure 41. Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure 42. Eosinophilic Esophagitis Drug Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fully Automatic Vehicle Disinfection Equipment Market Research Report 2026
Mar 14, 26
Global Heat Resistant FPC Market Research Report 2026
Mar 14, 26
Global Portable Recording Stick Market Research Report 2026
Mar 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232